ADDITIONAL TERMS AND CONDITIONS

• This Program is only valid for cost of the drug Adcirca, Orenitram, Remodulin, or Tyvaso and Tyvaso DPI and is not applicable to any related supplies or other medical expenses associated with administering the product.
• This Program is not conditioned on any past, present or future purchase, including refills.
• The patient confirms that this Program is consistent with patient's insurance. The patient is responsible for reporting the receipt of all Program benefits as required by the insurance company.
• This Program is not insurance and is not intended to substitute for insurance.
• Limit 1 (one) Co-Pay Identification Number per patient.
• This ID number is non-transferable and has no value.
• Patients, pharmacists, and prescribers cannot seek reimbursement from health insurance or any third party for any part of the benefit received by the Patient through this offer.
• United Therapeutics reserves the right to modify or terminate this program at any time without notice.
• By enrolling in the Program, you agree that your personal information may be used by United Therapeutics and its affiliates to send you information about United Therapeutics products, programs, support and services related to your condition and contact you in connection with your participation in the Program and as provided in our Privacy Policy. United Therapeutics respects the privacy of your personal information and you may unsubscribe from our programs at any time by calling 1-844-864-8437.